Short Float History | News | Indicators | Short Stats | Earnings History | Technical Averages | RGNX Yahoo Finance Page


Note: We have detected that our data provider shows 0 for short interest. Please manually confirm and if different, disregard the short data and short pain data below.

$58.99 -5.92%

549,292 Shares Traded
455,557 Average Volume (last 30 days)

as of November 14, 2018 EST IEX Real-Time Price

Click Here to Short Float History Versus Price & Peer Short Floats

Free Newsletter Sign Up


REGENXBIO's RGX-181 an Orphan Drug in U.S. for Batten disease (SeekingAlpha)
FDA Grants Orphan Drug Designation To RGX-181 Gene Therapy For The Treatment Of CLN2 Form Of Batten Disease (PR Newswire)

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $0
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-80.43%
If Intiated One Month Ago, Shorts Have Realized a Return of:1.95%
If Initiated Five Days ago, Shorts Have Realized a Return of:15.04%
Peer Rising Stocks Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points.

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 0%
Short Interest0
Float35.32 million
Short Ratio0
Market Cap$2.25 billion
Market Maker ActivityDaily Short Volume

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 54%

Earnings Stats

PE Ratio 28.37
Dividend Yield 0%

Earnings History For RGNX

Earnings DateQuarterConsensus EPSActual EPSEPS Surprise
2018-11-07 AMCQ3 2018-0.86 (1 Estimates) -0.560.3
2018-08-08 BTOQ2 20181.9 (1 Estimates) 0.15-1.75
2018-05-08 AMCQ1 20181.56 (1 Estimates) 31.44
2018-03-06 AMCQ4 2017-0.71 (2 Estimates) -0.510.2


200 Day Moving Average $53.93
50 Day Moving Average $67.47
52 Week High $85.1
52 Week Low $23.25

Back to the Top

Data provided for free by IEX. Questions? Read the FAQ